Bradley Foster & Sargent Inc Organon & Co. Transaction History

Bradley Foster & Sargent Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$31.66 - $38.9 $24,124 - $29,641	-762 Reduced 10.63%	6,406 $216,000
Q1 2022 May 16, 2022	SELL	$30.45 - $39.36 $8,495 - $10,981	-279 Reduced 3.75%	7,168 $250,000
Q4 2021 Mar 11, 2022	SELL	$28.67 - $37.13 $17,660 - $22,872	-616 Reduced 7.64%	7,447 $227,000
Q3 2021 Nov 10, 2021	SELL	$28.63 - $35.64 $182,745 - $227,490	-6,383 Reduced 44.19%	8,063 $264,000
Q2 2021 Aug 19, 2021	BUY	$28.45 - $38.0 $410,988 - $548,948	14,446 New	14,446 $437,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

Stay updated on Bradley Foster & Sargent Inc with notifications on news.